Clinical Trial Update: REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs [NA]

View source ↗

Summary

A clinical trial is investigating remote ischemic conditioning to prevent cardiac toxicity in lymphoma patients treated with anthracyclines; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthracycline-induced Cardiac Toxicity
• Lymphoma

Snippet

Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III | Conditions: Anthracycline-induced Cardiac Toxicity, Lymphoma | NA | Status: RECRUITING